In a nationwide retrospective cohort study of 75,693 adults in Georgia who achieved sustained virologic response after hepatitis C treatment, diabetes mellitus was linked to a 53% higher tuberculosis incidence (aIRR 1.53; 95% CI, 1.09-2.07). Published in Open Forum Infectious Diseases, the study also found an overall TB incidence of 136 per 100,000 person-years after HCV cure, underscoring that your frontline follow-up can catch risks specialists may miss.

Why It Matters To Your Practice

• Even after successful HCV treatment, patients remained at elevated TB risk, with 544 new TB cases over 399,504 person-years of follow-up.

• Diabetes mellitus and underweight status stood out as independent risk factors, giving NPs and PAs clear, actionable targets during routine chronic disease follow-up.

• Your role is central here: this is exactly the kind of longitudinal, whole-patient surveillance that advanced practice clinicians lead every day.

Clinical Benefits

• Screening for DM in post-HCV patients may help identify who needs closer TB symptom review and follow-up.

• Nutritional assessment, including low BMI or underweight status, can add another practical layer to TB risk stratification.

• Because you often manage diabetes, weight trends, and preventive counseling directly, you are well positioned to translate these findings into earlier detection.

Managing Risks

• Keep TB on the differential when post-HCV cure patients with DM present with cough, fever, weight loss, or night sweats.

• Consider more deliberate symptom screening and care coordination for patients with DM or poor nutritional status, especially in higher-burden settings.

• Interpret the findings with appropriate caution: the study was retrospective, had missing BMI and behavioral data, and lacked HIV status for adjustment.

The Bottom Line

• HCV cure does not reset TB risk to baseline, and DM meaningfully raises that risk.

• For NPs and PAs, this is a reminder that your ongoing chronic care management is not secondary work—it is the frontline where TB risk can be recognized sooner and acted on faster.

• Adding DM screening and nutritional assessment to post-HCV follow-up could strengthen TB prevention and earlier case finding.